Buserelin dosing & administration
A synthetic GnRH agonist that suppresses hormones to help treat prostate cancer, endometriosis, and infertility
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Dosing
How much do I take?
Subcutaneous: A small injection into the fatty layer just under the skin — the same way insulin is given.
Bioavailability High — most of the dose reaches your bloodstream, just more gradually than an IV.
2 documented dose levels — separate regimens, not a titration schedule
500 mcg
Frequency
Every 8 hours (3 times daily)
Duration
First 7 days
The product label starts prostate cancer treatment with 500 mcg under the skin every 8 hours for the first week [5].
200 mcg
Frequency
Once daily
Duration
Ongoing maintenance
After the first week, the label switches to 200 mcg once daily under the skin for ongoing treatment [5].
Timing
Best time to take
Administer Buserelin at the same time each day (or on the same day each week for weekly injections). Many users prefer morning or evening administration. Pick a time you'll remember consistently.
With food?
Buserelin injections can be given regardless of meal timing. However, if GI effects occur, administering on an empty stomach or with a light meal may help reduce discomfort.
If stacking
Buserelin should be used as directed by your healthcare provider. If combining with other medications or supplements, discuss potential interactions with your provider. Avoid combining with compounds that have overlapping mechanisms unless specifically guided by a medical professional.
Adjusting your dose
Increase if
- You've tolerated the current dose for the recommended period without significant side effects
- Therapeutic goals haven't been met at the current dose level
- Your healthcare provider recommends dose escalation based on your response
- Lab work or clinical assessments support a higher dose
Decrease if
- Side effects are bothersome or impacting daily life despite management strategies
- You experience any signs of an adverse reaction
- Lab results indicate the need for dose reduction
- Your healthcare provider recommends a lower dose based on your response
Signs of right dose
- Therapeutic goals being met with minimal side effects
- Stable and consistent response to treatment
- Lab values or clinical markers trending in the right direction
- Good tolerance with manageable or absent side effects
Administration
How do I use it?
Reconstitution
What you need
Injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Storage
Before reconstitution
Store Buserelin in the refrigerator at 36-46°F (2-8°C) in its original packaging. Protect from light and moisture. Do not freeze. Check the expiration date before use. Some formulations may be stored at room temperature for limited periods—check your specific product labeling.
After reconstitution
Once reconstituted, Buserelin should be kept refrigerated at 36-46°F (2-8°C) and used within the timeframe specified on your product labeling (typically 14-28 days). Label the vial with the reconstitution date. Do not use if the solution appears cloudy, discolored, or contains particles.
Signs of degradation — discard the vial
Sample daily schedule
As prescribed (once daily)
As prescribed by your healthcare provider injection
Site: Subcutaneous injection—rotate sites if applicable
Maintain a consistent schedule for optimal results with Buserelin. Set reminders if needed. If you miss a dose, follow your healthcare provider's instructions—do not double up on doses to compensate.
Safety
Is it safe?
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Buserelin
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Buserelin should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
Flagged pairings
- Other GnRH agonists—redundant and increases side effects — Use with caution—discuss with your healthcare provider.
- Alcohol in excess—may worsen hot flashes and mood changes — Use with caution—discuss with your healthcare provider.
Published research
What the studies show
PubMed Central · 1990
Buserelin effectively suppressed natural hormone surges during fertility treatment, allowing doctors to better control egg production timing. A simplified single daily 600 mcg injection proved as effective as more complex dosing schedules.
Raja T, Sud R, Addla S · 2022
Buserelin achieved testosterone suppression below 50 ng/dL within one month, with long-term survival rates of 42-84% depending on treatment approach. When combined with other therapies, survival improved further to 87% in some patient groups.
Cicione A, Nacchia A, Guercio A · 2023
Real-world data showed buserelin had higher cardiovascular complication rates (9%) compared to modern antagonists. Patients under 65 years experienced very low cardiovascular risk, while older populations showed significant complications requiring monitoring.
Chen Y, Lu W, Liao R · 2025
Buserelin showed distinct adverse effect profiles compared to other GnRH agonists, with higher incidence of gastrointestinal disorders. Pediatric patients experienced lower serious adverse event rates than adults, requiring different safety monitoring strategies.
Sanofi-aventis Canada Inc. · 2015
Prostate cancer dosing: 500 mcg subcutaneous every 8 hours for 7 days, then 200 mcg daily subcutaneous or 400 mcg intranasal three times daily; depot implants of 6.3 mg (2 months) and 9.45 mg (3 months).
Head to head
Buserelin compared
Want the full picture?
The complete Buserelin research profile: mechanism of action, clinical studies, effectiveness timeline, and FAQ.